<iframe src="//www.googletagmanager.com/ns.html?id=GTM-MX3DVL" height="0" width="0" style="display:none;visibility:hidden"></iframe>Pestalozzi advised Johnson & Johnson on the CHF 30 million capital increase for the acquisition of an equity stake in Biocartis SA | Pestalozzi Attorneys at Law

Pestalozzi advised Johnson & Johnson on the CHF 30 million capital increase for the acquisition of an equity stake in Biocartis SA

03.2010

Johnson & Johnson took an equity stake in Biocartis, a commercial stage molecular diagnostics (MDx) company. For this purpose it increased its capital by CHF 30 million. Pestalozzi advised Johnson & Johnson on its role as co-investor.

To the top